Search

Search Constraints

You searched for: Author/Creator Freeman, Gordon

Search Results

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

3. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers. Issue 1 (December 2016)

4. An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma. (June 2013)

5. Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer. Issue 10 (13th November 2018)

6. IMMU-09. CONCURRENT DEXAMETHASONE LIMITS THE CLINICAL BENEFIT OF IMMUNE CHECKPOINT BLOCKADE IN GLIOBLASTOMA. (9th November 2020)

7. IMMU-19. PD-1 BLOCKADE ACTIVATES CD4 T CELLS AND THE INNATE IMMUNE RESPONSE FOR GLIOBLASTOMA ERADICATION. (5th November 2018)

9. Level of PD-1 expression on CD8+ T cells influence prognosis and respond to PD-1 therapy in a murine model. Issue 2 (December 2015)

10. Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study. Issue 1 (December 2015)